SCHEMBL3107767

SCHEMBL3107767

Cc1nc2ccc(Nc3nc(N)nc(NCc4ccco4)n3)cc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.58
▸ KCNH3 Q9ULD8 3/20 0.51
▸ MAPT P10636 9/20 0.48
▸ MAPK1 P28482 5/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ EGFR P00533 1/20 0.47
▸ KMT2A Q03164 7/20 0.47
▸ RECQL P46063 2/20 0.47
▸ LMNA P02545 4/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ BLM P54132 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ SOS1 Q07889 1/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.45
▸ USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1392166 0.95 TSHR (0.64) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1390978 0.91 TSHR (0.59) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1390992 0.90 MAPK1 (0.61) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1391174 0.89 KMT2A (0.62) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1391224 0.86 TSHR (0.55) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1390767 0.86 MAPT (0.63) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1392051 0.82 TSHR (0.50) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL1392162 0.79 MAPT (0.63) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL5032270 0.73 KCNH3 (0.59) TSHRKCNH3MAPTMAPK1ALDH1A1
SCHEMBL6729004 0.72 MAPT (0.53) TSHRKCNH3MAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231624-A2 TRIAZINES AND RELATED COMPOUNDS HAVING ANTIVIRAL ACTIVITY, COMPOSITIONS AND METHODS THEREOF Progenics Pharmaceuticals, Inc. (US) 2010-09-29 — — EP disclosed
WO-2009091388-A2 TRIAZINES AND RELATED COMPOUNDS HAVING ANTIVIRAL ACTIVITY, COMPOSITIONS AND METHODS THEREOF PROGENICS PHARMACEUTICALS, INC. (US) 2009-07-23 — — WO disclosed
Send feedback